Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users

Brian R. Edlin, Thomas F. Kresina, Daniel B. Raymond, Michael R. Carden, Marc Gourevitch, Josiah D. Rich, Laura W. Cheever, Victoria A. Cargill

Research output: Contribution to journalArticle

Abstract

Injection drug use accounts for most of the incident infections with hepatitis C virus (HCV) in the United States and other developed countries. HCV infection is a complex and challenging medical condition in injection drug users (IDUs). Elements of care for hepatitis C in illicit drug users include prevention counseling and education; screening for transmission risk behavior; testing for HCV and human immunodeficiency virus infection; vaccination against hepatitis A and B viruses; evaluation for comorbidities; coordination of substance-abuse treatment services, psychiatric care, and social support; evaluation of liver disease; and interferon-based treatment for HCV infection. Caring for patients who use illicit drugs presents challenges to the health-care team that require patience, experience, and an understanding of the dynamics of substance use and addiction. Nonetheless, programs are successfully integrating hepatitis C care for IDUs into health-care settings, including primary care, methadone treatment and other substance-abuse treatment programs, infectious disease clinics, and clinics in correctional facilities.

Original languageEnglish (US)
JournalClinical Infectious Diseases
Volume40
Issue numberSUPPL. 5
DOIs
StatePublished - Apr 15 2005

Fingerprint

Street Drugs
Hepatitis C
Drug Users
Hepacivirus
Virus Diseases
Substance-Related Disorders
Injections
Hepatitis A virus
Patient Care Team
Methadone
Therapeutics
Risk-Taking
Developed Countries
Hepatitis B virus
Social Support
Interferons
Communicable Diseases
Psychiatry
Comorbidity
Liver Diseases

ASJC Scopus subject areas

  • Immunology

Cite this

Edlin, B. R., Kresina, T. F., Raymond, D. B., Carden, M. R., Gourevitch, M., Rich, J. D., ... Cargill, V. A. (2005). Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clinical Infectious Diseases, 40(SUPPL. 5). https://doi.org/10.1086/427441

Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. / Edlin, Brian R.; Kresina, Thomas F.; Raymond, Daniel B.; Carden, Michael R.; Gourevitch, Marc; Rich, Josiah D.; Cheever, Laura W.; Cargill, Victoria A.

In: Clinical Infectious Diseases, Vol. 40, No. SUPPL. 5, 15.04.2005.

Research output: Contribution to journalArticle

Edlin, BR, Kresina, TF, Raymond, DB, Carden, MR, Gourevitch, M, Rich, JD, Cheever, LW & Cargill, VA 2005, 'Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users', Clinical Infectious Diseases, vol. 40, no. SUPPL. 5. https://doi.org/10.1086/427441
Edlin, Brian R. ; Kresina, Thomas F. ; Raymond, Daniel B. ; Carden, Michael R. ; Gourevitch, Marc ; Rich, Josiah D. ; Cheever, Laura W. ; Cargill, Victoria A. / Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. In: Clinical Infectious Diseases. 2005 ; Vol. 40, No. SUPPL. 5.
@article{00436a564298476daf68e636bdf1935c,
title = "Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users",
abstract = "Injection drug use accounts for most of the incident infections with hepatitis C virus (HCV) in the United States and other developed countries. HCV infection is a complex and challenging medical condition in injection drug users (IDUs). Elements of care for hepatitis C in illicit drug users include prevention counseling and education; screening for transmission risk behavior; testing for HCV and human immunodeficiency virus infection; vaccination against hepatitis A and B viruses; evaluation for comorbidities; coordination of substance-abuse treatment services, psychiatric care, and social support; evaluation of liver disease; and interferon-based treatment for HCV infection. Caring for patients who use illicit drugs presents challenges to the health-care team that require patience, experience, and an understanding of the dynamics of substance use and addiction. Nonetheless, programs are successfully integrating hepatitis C care for IDUs into health-care settings, including primary care, methadone treatment and other substance-abuse treatment programs, infectious disease clinics, and clinics in correctional facilities.",
author = "Edlin, {Brian R.} and Kresina, {Thomas F.} and Raymond, {Daniel B.} and Carden, {Michael R.} and Marc Gourevitch and Rich, {Josiah D.} and Cheever, {Laura W.} and Cargill, {Victoria A.}",
year = "2005",
month = "4",
day = "15",
doi = "10.1086/427441",
language = "English (US)",
volume = "40",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "SUPPL. 5",

}

TY - JOUR

T1 - Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users

AU - Edlin, Brian R.

AU - Kresina, Thomas F.

AU - Raymond, Daniel B.

AU - Carden, Michael R.

AU - Gourevitch, Marc

AU - Rich, Josiah D.

AU - Cheever, Laura W.

AU - Cargill, Victoria A.

PY - 2005/4/15

Y1 - 2005/4/15

N2 - Injection drug use accounts for most of the incident infections with hepatitis C virus (HCV) in the United States and other developed countries. HCV infection is a complex and challenging medical condition in injection drug users (IDUs). Elements of care for hepatitis C in illicit drug users include prevention counseling and education; screening for transmission risk behavior; testing for HCV and human immunodeficiency virus infection; vaccination against hepatitis A and B viruses; evaluation for comorbidities; coordination of substance-abuse treatment services, psychiatric care, and social support; evaluation of liver disease; and interferon-based treatment for HCV infection. Caring for patients who use illicit drugs presents challenges to the health-care team that require patience, experience, and an understanding of the dynamics of substance use and addiction. Nonetheless, programs are successfully integrating hepatitis C care for IDUs into health-care settings, including primary care, methadone treatment and other substance-abuse treatment programs, infectious disease clinics, and clinics in correctional facilities.

AB - Injection drug use accounts for most of the incident infections with hepatitis C virus (HCV) in the United States and other developed countries. HCV infection is a complex and challenging medical condition in injection drug users (IDUs). Elements of care for hepatitis C in illicit drug users include prevention counseling and education; screening for transmission risk behavior; testing for HCV and human immunodeficiency virus infection; vaccination against hepatitis A and B viruses; evaluation for comorbidities; coordination of substance-abuse treatment services, psychiatric care, and social support; evaluation of liver disease; and interferon-based treatment for HCV infection. Caring for patients who use illicit drugs presents challenges to the health-care team that require patience, experience, and an understanding of the dynamics of substance use and addiction. Nonetheless, programs are successfully integrating hepatitis C care for IDUs into health-care settings, including primary care, methadone treatment and other substance-abuse treatment programs, infectious disease clinics, and clinics in correctional facilities.

UR - http://www.scopus.com/inward/record.url?scp=16844384955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16844384955&partnerID=8YFLogxK

U2 - 10.1086/427441

DO - 10.1086/427441

M3 - Article

VL - 40

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - SUPPL. 5

ER -